In Brief: Ascent Pediatrics
Executive Summary
Ascent Pediatrics: Company will promote Bristol-Myers Squibb's Duricef (cefadroxil) oral suspension under a four-year contract. Ascent's 64-person sales force will conduct all U.S. pediatric sales activities for the cephalosporin...